Project Number 20111202-Edison-2011 Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Year 2011 View Full Project Details for Effect of Novel GLP1 analogue, Liraglutide on microglial activation and cerebral glucose metabolism in mild Alzheimer's disease. Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 7. Early-stage Clinical Drug Development (Phase I and II Clinical Trials) j. Metabolism and Bioenergetics Researcher and Organization Principal Investigator Edison, Paul Principal Investigator First Name Paul Principal Investigator Last Name Edison Awardee Organization Imperial College London Contact PI Country United Kingdom Project Detail Funding Opportunity Announcement PACT Program FY Overall Cost $458,000 Funding Organization Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Organization Country United States
